Bunkerhill ECG-EF vs FEops HEARTguideTM

Loosely related. A direct comparison may be less useful — each tool solves a different problem. Comparability 40/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by FEops

AI Verdict

Bunkerhill ECG-EF focuses on early identification of heart failure risk by analyzing routine ECGs to detect reduced left ventricular ejection fraction. FEops HEARTguide, on the other hand, is designed for pre-procedural planning of structural heart interventions, utilizing AI and digital twin technology to optimize device sizing and positioning based on CT scans. While both are cardiology AI tools, their applications are distinct: one for risk detection and the other for procedural planning.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your health system aims for early, widespread screening of patients at risk for heart failure using routine 12-lead electrocardiograms (ECGs). This tool is ideal for identifying reduced left ventricular ejection fraction (LVEF ≤ 40%) in a non-invasive, rapid, and accessible manner, integrating with existing EHRs to support automated clinical workflows and flag high-risk patients sooner. It is particularly useful for large-scale patient identification before severe symptoms appear, as it leverages a common diagnostic test.

View Bunkerhill ECG-EF →

Choose FEops HEARTguideTM if…

Choose FEops HEARTguide™ if your cardiology department requires advanced, patient-specific pre-procedural planning for structural heart interventions like TAVI and LAAO. This cloud-based platform utilizes AI and digital twin technology to provide predictive simulations and detailed anatomical insights from CT scans, optimizing device sizing and positioning. It is best suited for complex cases where precise understanding of device-anatomy interaction is crucial to improve procedure efficiency and outcomes, reducing complications such as paravalvular leakage or conduction abnormalities.

View FEops HEARTguideTM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill ECG-EF FEops HEARTguideTM
Pricing Contact sales for pricing details. Unknown
Deployment Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. Cloud-based
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FEops HEARTguideTM

FEops HEARTguide™ emphasizes an intuitive and easy-to-use interface, with features like semi-automatic identification of anatomical landmarks, interactive 2D and 3D viewers, and a DICOM interface for seamless integration into clinical workflows. It also offers a collaborative platform for case sharing. Bunkerhill ECG-EF, while integrated into the Carebricks platform for automated workflows, doesn't provide as much specific detail on its direct user interface or interactive features for clinicians.

Clinical Value

FEops HEARTguideTM

FEops HEARTguide™ has demonstrated significant clinical value through multiple studies, showing improved procedural efficiency, reduced complications, and better patient outcomes in LAAO and TAVI procedures. It provides predictive simulations that help optimize device sizing and positioning, directly impacting procedural success. Bunkerhill ECG-EF offers early identification of patients at risk for heart failure, which is valuable for population health, but FEops HEARTguide™ provides more direct, procedure-specific clinical impact with documented evidence of improved outcomes.

Pricing & Value

Tie

Both tools require direct contact with their sales teams for pricing details, indicating a lack of public transparency. Neither tool provides enough information to definitively assess which offers better value without specific pricing and contract terms. Therefore, it's a tie in this dimension due to insufficient comparative data.

Enterprise Readiness

Bunkerhill ECG-EF

Bunkerhill ECG-EF is deployed on the cloud-native Carebricks platform, designed for integration with existing health system infrastructure like EHRs, and aims to support automated clinical workflows at scale. It is already adopted by more than a dozen health systems. FEops HEARTguide™ is also cloud-based and integrates via DICOM, but Bunkerhill's explicit focus on health system integration and automated workflows within its Carebricks platform suggests a stronger emphasis on enterprise readiness and scalability within large healthcare organizations.

Innovation

FEops HEARTguideTM

FEops HEARTguide™ stands out with its innovative use of digital twin technology combined with AI for predictive simulations of device-anatomy interaction, offering unprecedented insights for structural heart procedure planning. This approach goes beyond traditional anatomical measurements. While Bunkerhill ECG-EF utilizes AI for early detection from ECGs, FEops' digital twin and predictive simulation capabilities represent a more novel and complex application of AI in cardiology.

Support & Docs

Tie

Both companies offer standard support channels, with FEops providing a dedicated support email and mentioning training slide decks on their platform. Bunkerhill Health, as part of its enterprise solution, would also be expected to provide comprehensive support and documentation. However, specific details on the depth and breadth of support and documentation for either tool are not extensively detailed in the provided information or search results, leading to a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill ECG-EF FEops HEARTguideTM
Name Bunkerhill ECG-EF FEops HEARTguideTM
Company BunkerHill Health FEops nv
Description FDA-cleared artificial intelligence algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO.
Key Functionality AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from 12-lead ECG data. Predictive simulation technology for device-anatomy interaction and AI-based anatomical measurements from CT scans.
Data Input Routine 12-lead ECG data CT scans
Target Condition/Procedure Reduced Left Ventricular Ejection Fraction (LVEF u2264 40%), early identification of patients at risk for heart failure. Structural heart procedure planning (e.g., TAVI, LAAO), device sizing and positioning optimization.

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and FEops HEARTguideTM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF is an FDA-cleared AI algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure. FEops HEARTguideTM is a cloud-based AI and digital twin platform focused on structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO.
Bunkerhill ECG-EF analyzes routine 12-lead electrocardiogram (ECG) data. FEops HEARTguideTM utilizes AI-based anatomical measurements derived from CT scans, integrating via a DICOM interface.
Bunkerhill ECG-EF integrates seamlessly with Electronic Medical Records (EMRs) or ECG Management Systems (EMS) and clinical archives, supporting automated clinical workflows. FEops HEARTguideTM is a cloud-based platform accessible from anywhere at any time, featuring a DICOM interface for easy integration into the clinical workflow.
Bunkerhill ECG-EF is designed for Cardiology, Emergency Medicine, and Internal Medicine. FEops HEARTguideTM is intended for use in Cardiology, Cardiothoracic Surgery, and Radiology.
Bunkerhill ECG-EF provides an AI algorithm-driven detection of reduced Left Ventricular Ejection Fraction (LVEF u2264 40%). FEops HEARTguideTM offers predictive simulation technology for device-anatomy interaction, AI-based anatomical measurements, and interactive 2D and 3D visualization for detailed analysis.
AI Tool Finder
AI-powered search. Results may not be comprehensive.